ITOS

iTeos Therapeutics, Inc. (ITOS) ESG Analysis Analysis (2026)

Invetso Score: 5.9/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.4 (Moderate)

ITOS appears to have limited disclosed environmental intensity metrics, which constrains peer comparison and leaves its relative positioning closer to the middle of the pack.

The provided data show no R&D-to-revenue environmental proxy and no gross margin disclosure, so environmental management cannot be evidenced as structurally stronger than peers.

Low leverage does not materially improve environmental positioning, because it affects capital structure more than emissions, resource use, or regulatory exposure versus peers.

Absent reported environmental controversies in the supplied data, ITOS avoids a clear disadvantage, but the lack of disclosed operational ESG metrics keeps its relative standing moderate.

Social

Score:

ITOS has no supplied workforce, safety, or customer-impact metrics, which limits evidence of social leadership relative to peers in a materially regulated environment.

The absence of stock-based compensation in the provided data may indicate lower dilution pressure, but it does not directly demonstrate stronger employee alignment than peers.

No social controversy data are provided, so ITOS avoids an identifiable peer disadvantage, yet the disclosure gap prevents a stronger relative social score.

Because social risk assessment depends on labor practices, product responsibility, and stakeholder management, the current evidence supports only a moderate peer position.

Governance

Score:

ITOS shows very low debt-to-equity at 0.01, which suggests conservative balance-sheet governance relative to more levered peers and reduces creditor pressure.

Net debt to EBITDA of 2.03 indicates manageable leverage, but it is not strong enough on its own to place ITOS clearly above well-capitalized peers.

Zero stock-based compensation in the supplied metrics supports tighter capital discipline than peers that rely heavily on equity incentives, improving governance quality.

However, the limited disclosure set prevents confirmation of board independence, audit quality, or shareholder-rights practices, keeping governance above average but not leading.

Overall Score

Score:

ITOS ranks as a moderate ESG performer versus peers because conservative leverage and limited compensation burden are offset by sparse disclosure across key environmental and social dimensions.

Score Driver: Governance Strength From Low Leverage And Restrained Equity Dilution

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on iTeos Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →